Mersana Therapeutics
MRSN
MRSN
128 hedge funds and large institutions have $144M invested in Mersana Therapeutics in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 35 increasing their positions, 43 reducing their positions, and 45 closing their positions.
Holders
128
Holders Change
-19
Holders Change %
-12.93%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
35
Reduced
43
Closed
45
Calls
$1.57M
Puts
$76K
Net Calls
+$1.49M
Net Calls Change
-$14.3M
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
176
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
|
JGC
177
J. Goldman & Co
New York
| – | – | – | – |
|
|
LPC
178
Lion Point Capital
New York
| – | – | – | – |
|
|
MCM
179
Moore Capital Management
New York
| – | – | – | – |
|
|
CG
180
Cutler Group
San Francisco,
California
| – | – | – | – |
|
|
GPP
181
Great Point Partners
Greenwich,
Connecticut
| – | – | – | – |
|
|
HT
182
HAP Trading
New York
| – | – | – | – |
|